Skip To The Main Content

FDA Announces New Homeopathic Products Enforcement Strategy

The United States Food and Drug Administration (FDA) has issued new enforcement guidance on homeopathic drug products.  The FDA announced it will use a risk-based priority approach that concentrates on homeopathic products with ingredients known to cause patient harm and on unproven claims about the homeopathic product being able to treat disease states.  To read the FDA announcement and summary of its new homeopathic products enforcement methodologies, use the link below.
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/UCM589243.htm?utm_campaign=12182017_PR_Homeopathy%20Guidance&utm_medium=email&utm_source=Eloqua
"State":"NY"